NDSI
APTO

Newman Dignan & Sheerar Inc’s Aptose Biosciences, Inc. APTO Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42
Closed -$12.1K – 197
2023
Q1 		$12.1K Hold
42
– – ﹤0.01% 193
2022
Q4 		$11K Hold
42
– – ﹤0.01% 190
2022
Q3 		$11 Buy
+42
New +$14.5K ﹤0.01% 183
2022
Q2 		– Sell
-42
Closed -$26 – 210
2022
Q1 		$26 Buy
42
+11
+35% +$6.08K 0.01% 193
2021
Q4 		$19K Buy
31
+2
+7% +$1.88K 0.01% 202
2021
Q3 		$28K Buy
+29
New +$36.3K 0.01% 190

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Newman Dignan & Sheerar Inc's APTO Position: Q2 2023 in Review

Newman Dignan & Sheerar Inc sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 42 shares — an estimated $12.1K sold.

Newman Dignan & Sheerar Inc first reported a position in APTO in Q3 2021 and held it in 6 quarters. The position peaked at $28K in Q3 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Newman Dignan & Sheerar Inc reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 42 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $12.1K.
  • Newman Dignan & Sheerar Inc first reported a position in Aptose Biosciences, Inc. in Q3 2021 and held it in 6 quarters.
  • Newman Dignan & Sheerar Inc's Aptose Biosciences, Inc. position peaked at $28K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2023, filed 2 Aug 2023.